Literature DB >> 33859818

Is heart disease a risk factor for low dementia test battery scores in older persons with Down syndrome? Exploratory, pilot study, and commentary.

Maire E Percy1,2,3, Walter J Lukiw4,5,6.   

Abstract

OBJECTIVES: Certain heart conditions and diseases are common in Down syndrome (DS; trisomy 21), but their role in early onset dementia that is prevalent in older adults with DS has not been evaluated. To address this knowledge gap, we conducted a study of risk factors for low neurocognitive/behavioral scores obtained with a published dementia test battery (DTB). Participants were adults with DS living in New York (N = 29; average age 46 years). We asked three questions. 1. Does having any type of heart disease affect the association between DTB scores and chronological age? 2. Does thyroid status affect the association between heart disease and DTB scores? 3. Are the E4 or E2 alleles of apolipoprotein E (APOE) associated with DTB scores or with heart disease?
METHOD: The study was retrospective, pilot, and exploratory. It involved analysis of information in a database previously established for the study of aging in DS. Participants had moderate intellectual disability on average. Information for each person included: gender, age, a single DTB score obtained by combining results from individual subscales of the DTB, the presence or absence of heart disease, thyroid status (treated hypothyroidism or normal), and APOE genotype. Trends were visualized by inspection of graphs and contingency tables. Statistical methods used to evaluate associations included Pearson correlation analysis, Fisher's exact tests (2-tailed), and odds ratio analysis. P values were interpreted at the 95% confidence level without Bonferroni correction. P values >.05<.1 were considered trends.
RESULTS: The negative correlation between DTB scores and age was significant in those with heart disease but not in those without. Heart disease was significantly associated with DTB scores >1 SD below the sample mean; there was a strong association between heart disease and low DTB scores in those with treated hypothyroidism but not in those with normal thyroid status. The APOE genotype was weakly associated with heart disease (E4, predisposing; E2, protective) in males.
CONCLUSIONS: On the basis of the potentially important findings from the present study, large prospective studies are warranted to confirm and extend the observations. In these, particular heart conditions or diseases and other medical comorbidities in individuals should be documented.

Entities:  

Keywords:  Alzheimer’s disease; Down syndrome; apolipoprotein E; cognitive function; dementia; dementia test battery; heart disease; hypoperfusion; hypothyroidism

Year:  2017        PMID: 33859818      PMCID: PMC8046177          DOI: 10.1080/20473869.2017.1301023

Source DB:  PubMed          Journal:  Int J Dev Disabil        ISSN: 2047-3869


  115 in total

1.  Alzheimer's disease, a multifactorial disorder seeking multitherapies.

Authors:  Khalid Iqbal; Inge Grundke-Iqbal
Journal:  Alzheimers Dement       Date:  2010-09       Impact factor: 21.566

Review 2.  Management of pulmonary hypertension and Down syndrome.

Authors:  P King; R Tulloh
Journal:  Int J Clin Pract Suppl       Date:  2011-12

3.  Thyroid function and the risk of Alzheimer disease: the Framingham Study.

Authors:  Zaldy S Tan; Alexa Beiser; Ramachandran S Vasan; Rhoda Au; Sanford Auerbach; Douglas P Kiel; Philip A Wolf; Sudha Seshadri
Journal:  Arch Intern Med       Date:  2008-07-28

Review 4.  Thyroid disease and the heart.

Authors:  Irwin Klein; Sara Danzi
Journal:  Circulation       Date:  2007-10-09       Impact factor: 29.690

5.  Domains of genome-wide gene expression dysregulation in Down's syndrome.

Authors:  Audrey Letourneau; Federico A Santoni; Ximena Bonilla; M Reza Sailani; David Gonzalez; Jop Kind; Claire Chevalier; Robert Thurman; Richard S Sandstrom; Youssef Hibaoui; Marco Garieri; Konstantin Popadin; Emilie Falconnet; Maryline Gagnebin; Corinne Gehrig; Anne Vannier; Michel Guipponi; Laurent Farinelli; Daniel Robyr; Eugenia Migliavacca; Christelle Borel; Samuel Deutsch; Anis Feki; John A Stamatoyannopoulos; Yann Herault; Bas van Steensel; Roderic Guigo; Stylianos E Antonarakis
Journal:  Nature       Date:  2014-04-17       Impact factor: 49.962

6.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

7.  Heart diseases and long-term risk of dementia and Alzheimer's disease: a population-based CAIDE study.

Authors:  Minna Rusanen; Miia Kivipelto; Esko Levälahti; Tiina Laatikainen; Jaakko Tuomilehto; Hilkka Soininen; Tiia Ngandu
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 8.  The 50th anniversary of the discovery of trisomy 21: the past, present, and future of research and treatment of Down syndrome.

Authors:  André Mégarbané; Aimé Ravel; Clotilde Mircher; Franck Sturtz; Yann Grattau; Marie-Odile Rethoré; Jean-Maurice Delabar; William C Mobley
Journal:  Genet Med       Date:  2009-09       Impact factor: 8.822

Review 9.  A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.

Authors:  Frances K Wiseman; Tamara Al-Janabi; John Hardy; Annette Karmiloff-Smith; Dean Nizetic; Victor L J Tybulewicz; Elizabeth M C Fisher; André Strydom
Journal:  Nat Rev Neurosci       Date:  2015-08-05       Impact factor: 34.870

10.  Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia.

Authors:  Jack C de la Torre
Journal:  Cardiovasc Psychiatry Neurol       Date:  2012-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.